2020 Australian Pharmaceutical Industries Ltd – Financial & Strategic SWOT Analysis Review – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Australian Pharmaceutical Industries Ltd (API) – Financial and Strategic SWOT Analysis Review” swot analysis has been added to ResearchAndMarkets.com’s offering.

Australian Pharmaceutical Industries Ltd (API) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Australian Pharmaceutical Industries Ltd (API) is an integrated healthcare service provider. The company produces, retails, markets and sells pharmaceutical, health and beauty care products. It markets these products under various brand names such as Priceline & Priceline Pharmacy, Clearskincare, Soul Pattinson Chemist, Pharmacist Advice, Club Premium and Pharmacy Best Buys. API procures various health, beauty, and lifestyle products and sells them on retail basis. It also manufactures pharmaceutical products; and owns rights of medicines and consumer toiletries in New Zealand. The company also offers pharmacy services, professional care services and counselling for various patients related to specific medication needs. API is headquartered in Camberwell, Victoria, Australia.

Key benefits of buying this profile include:

• You get detailed information about the company and its operations to identify potential customers and suppliers.
• Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
• Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
• Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
• Gain key insights into the company for academic or business research.

Key Topics Covered:

Section 1 – About the Company

• Australian Pharmaceutical Industries Ltd – Key Facts
• Australian Pharmaceutical Industries Ltd – Key Employees
• Australian Pharmaceutical Industries Ltd – Key Employee Biographies
• Australian Pharmaceutical Industries Ltd – Major Products and Services
• Australian Pharmaceutical Industries Ltd – History
• Australian Pharmaceutical Industries Ltd – Company Statement
• Australian Pharmaceutical Industries Ltd – Locations And Subsidiaries
• Head Office
• Other Locations & Subsidiaries

Section 2 – Company Analysis

• Company Overview
• Australian Pharmaceutical Industries Ltd – Business Description
• Geographical Segment: Australia
• Performance
• Overview
• Geographical Segment: New Zealand
• Australian Pharmaceutical Industries Ltd – Corporate Strategy
• Australian Pharmaceutical Industries Ltd – SWOT Analysis
• SWOT Analysis – Overview
• Australian Pharmaceutical Industries Ltd – Strengths
• Australian Pharmaceutical Industries Ltd – Weaknesses
• Australian Pharmaceutical Industries Ltd – Opportunities
• Australian Pharmaceutical Industries Ltd – Threats
• Australian Pharmaceutical Industries Ltd – Key Competitors

Section 3 – Company Financial Ratios

• Financial Ratios – Capital Market Ratios
• Financial Ratios – Annual Ratios
• Performance Chart
• Financial Performance
• Financial Ratios – Interim Ratios
• Financial Ratios – Ratio Charts
• Australian Pharmaceutical Industries Ltd, Recent Deals Summary

Section 4 – Appendix

• Methodology
• Ratio Definitions
• About the Publisher
• Contact Us
• Disclaimer

Companies Mentioned

• Suda Pharmaceuticals Ltd
• Sigma Healthcare Ltd
• Kazia Therapeutics Ltd
• Discount Drug Stores Pty Ltd
• Amway of Australia Pty Ltd

For more information about this swot analysis visit https://www.researchandmarkets.com/r/eeii1x

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900